| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |